Oxygenta Pharma (524636)
TURNAROUNDScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹32.25 |
| Market Cap | ₹121.7 Cr |
| P/E Ratio | 0 |
| ROCE | -24.93% |
| ROE | 85.3% |
| Dividend Yield | 0% |
| Profit Growth | -23.16% |
| Debt/Equity | — |
| Sales Growth | 2.17% |
| 52-Week Range | ₹45.3 — ₹129.6 |
| Sector | Pharmaceuticals & Biotechnology |
Oxygenta Pharma trades with ROCE of -24.93%, ROE of 85.3%, profit growth of -23.16%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer